The FTC will require Novartis (NVS +0.3%) to give up its marketing rights to four topical skin...

|About: Novartis AG (NVS)|By:, SA News Editor

The FTC will require Novartis (NVS +0.3%) to give up its marketing rights to four topical skin care medications as part of its $1.5B acquisition of Fougera. Novartis has an agreement for the treatments with Tolmar. (FTC PR)